Forchheimer spots, also known as petechiae, are small, purplish spots on the skin that are caused by bleeding underneath the surface. They are usually seen on the arms, legs, and trunk. Although these spots are not usually a cause for concern, they can indicate a more serious underlying condition. In this article, we will discuss what Forchheimer spots are, how they are caused, and how to prevent them.
Forchheimer spots are small, round, purplish spots that appear on the skin. They are caused by bleeding underneath the surface of the skin, and they vary in size from 1-3 millimeters. They are most commonly seen on the arms, legs, and trunk, but they can also appear on other areas of the body.
Forchheimer spots are usually caused by minor trauma, such as a bump or bruise. They can also be caused by certain medications, such as aspirin or anticoagulants. In rare cases, they can be caused by an underlying medical condition, such as leukemia or thrombocytopenia.
The most common symptom of Forchheimer spots is the presence of small, round, purplish spots on the skin. These spots are usually painless and may be itchy or tender to the touch. In some cases, the spots may be accompanied by swelling and redness.
Forchheimer spots can usually be diagnosed by a physical examination. Your doctor may also order a blood test to check for an underlying medical condition. In some cases, a biopsy may be necessary to rule out other conditions.
Forchheimer spots are usually not a cause for concern and do not require treatment. However, if the spots are accompanied by swelling or redness, your doctor may prescribe anti-inflammatory medications or antibiotics to help reduce the symptoms.
The best way to prevent Forchheimer spots is to avoid activities that can cause minor trauma to the skin, such as contact sports or rough play.
Forchheimer spots are small, round, purplish spots on the skin that are caused by bleeding underneath the surface. They are usually not a cause for concern and do not require treatment. However, they can indicate an underlying medical condition, so it is important to talk to your doctor if you notice any changes in your skin.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation